Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group

发表于 2026-9-10 14:38:35

期刊：Bone Marrow Transplantation

文献作者：Lan-Ping Xu; Pei-Hua Lu; De-Pei Wu; He Huang; Er-Lie Jiang; Dai-Hong Liu; Wei-Jie Cao; Xi Zhang; Yue-Wen Fu; Nai-Nong Li; Xin-Chuan Chen; Xiao-Yu Zhu; Qi-Fa Liu; Ling-Hui Xia; Yi-Cheng Zhang; Ya-Jing Xu; Fu-Chun Li; Jiong Hu; Si-Xi Liu; Rong-Rong Liu; Xiao-Di Ma; Xiao-Wen Tang; Yi Luo; Xiao-Hui Zhang; Xiao-Jun Huang;

出版日期：2024-12-

DOI号：10.1038/s41409-024-02419-8

下载链接：https://www.nature.com/articles/s41409-024-02419-8.pdf

文献链接：https://doi.org/10.1038/s41409-024-02419-8

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

[Nature] Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Nature] Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group 一键复制